Sabinsa (East Windsor, NJ) filed law suits in the United States District Court for the District of New Jersey against four dietary supplement ingredient companies for selling products that infringe upon Sabinsa’s Curcumin C3 Complex® patent covering compositions, methods of use, and methods of extraction of a nutritional supplement in the U.S., reported the company
Being sued are Olive Lifesciences Pvt. Ltd. (Bangalore, India), U.S. distributor NutriBioLink LLC (Brooklyn, NY), Prakruti Products Pvt. Ltd. (Karnataka, India) and U.S. distributor HerbaKraft (Piscataway, NJ).
“We are determined to protect our intellectual property even if it takes us to a court of law,” said Muhammed Majeed PhD, founder of Sabinsa. “We have been very outspoken in encouraging industry manufacturers to respect intellectual property; to do otherwise both stifles innovation and does a disservice to those manufacturers who legitimately license intellectual property.”
James H. Hulme, attorney for Sabinsa, said the company’s patent claims the composition, methods of use, and methods of extraction of its Curcumin complex. “Sabinsa will enforce its patent rights and protect its intellectual property to the fullest extent allowed by law,” said Hulme.
Sabinsa’s patent means that while other companies can certainly sell a variety of curcumin products, they may not sell knock offs of Sabinsa’s unique composition ratio, market it for its antioxidant use or use the ethyl acetate extraction method developed by Sabinsa and outlined in Sabinsa’s patent, reported the company.
For more information, visit www.sabinsa.com.
